Hepatocellular Carcinoma: Diagnosis and Management


Related Videos (27)

In this presentation, Maalouf Hoteit, MD, examines the current state of hepatocellular carcinoma diagnosis, treatment and prevention from the perspective that early screening and treatment of hepatitis C and early treatment of liver cancer holds the greatest promise patients at risk for the disease. Includes a discussion of the PD-1 inhibitor nivolumab, the latest addition to the armamentarium for advanced HCC.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®